Stockscreener 앱 받기
0.84
0.94%
0.0103
시간 외 거래:
.83
-0.01
-1.19%
전일 마감가:
$0.8297
열려 있는:
$0.827
하루 거래량:
605.86K
Relative Volume:
0.46
시가총액:
$82.87M
수익:
-
순이익/손실:
$-93.61M
주가수익비율:
-0.3981
EPS:
-2.11
순현금흐름:
$-71.16M
1주 성능:
-1.70%
1개월 성능:
-14.41%
6개월 성능:
-25.88%
1년 성능:
-53.21%
1일 변동 폭
$0.8211
$0.85
1주일 범위
$0.752
$0.888
52주 변동 폭
$0.561
$2.11
Immunic Inc Stock (IMUX) Company Profile
명칭
Immunic Inc
전화
(332) 255-9818
주소
1200 AVENUE OF THE AMERICAS, NEW YORK
IMUX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMUX
Immunic Inc
|
0.84 | 81.85M | 0 | -93.61M | -71.16M | -2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.11 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.71 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.17 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
731.77 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
342.89 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunic Inc Stock (IMUX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-25 | 개시 | William Blair | Outperform |
| 2024-11-25 | 개시 | H.C. Wainwright | Buy |
| 2024-09-09 | 재개 | Leerink Partners | Outperform |
| 2024-08-27 | 개시 | B. Riley Securities | Buy |
| 2022-10-21 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-19 | 재개 | H.C. Wainwright | Buy |
| 2021-04-15 | 개시 | Aegis Capital | Buy |
| 2021-03-24 | 개시 | JMP Securities | Mkt Outperform |
| 2020-10-02 | 개시 | SVB Leerink | Outperform |
| 2020-08-26 | 개시 | Piper Sandler | Overweight |
| 2020-08-07 | 재개 | ROTH Capital | Buy |
| 2020-07-20 | 개시 | BMO Capital Markets | Outperform |
| 2020-06-05 | 개시 | Wedbush | Outperform |
| 2020-05-11 | 개시 | H.C. Wainwright | Buy |
| 2020-03-25 | 개시 | ROTH Capital | Buy |
| 2019-07-11 | 개시 | Chardan Capital Markets | Buy |
모두보기
Immunic Inc 주식(IMUX)의 최신 뉴스
Pullback Watch: Does Immunic Inc stock have upside surprise potential2025 Key Lessons & Weekly Watchlist for Consistent Profits - خودرو بانک
Focus Partners Wealth Raises Holdings in Immunic, Inc. $IMUX - MarketBeat
Aug Movers: Is Immunic Inc stock a good dividend stock2025 Price Momentum & Free Expert Verified Stock Movement Alerts - خودرو بانک
Using Bollinger Bands to evaluate Immunic Inc.Weekly Loss Report & Reliable Trade Execution Plans - newser.com
Immunic Inc. stock chart pattern explained2025 Pullback Review & Pattern Based Trade Signal System - newser.com
Chart overlay techniques for tracking Immunic Inc.Market Weekly Review & Fast Entry High Yield Stock Tips - newser.com
Bearish Setup: Can Immunic Inc. ride the EV waveJuly 2025 Sentiment & Fast Exit and Entry Trade Guides - خودرو بانک
Aug Big Picture: Whats next for Immunic Inc stockJuly 2025 Highlights & High Accuracy Investment Signals - خودرو بانک
Chart Watch: Is Immunic Inc a potential multi baggerSwing Trade & Technical Pattern Based Signals - خودرو بانک
Published on: 2025-09-15 06:02:09 - newser.com
Retail Trends: Does Immunic Inc stock have upside surprise potential2025 Historical Comparison & Fast Exit/Entry Strategy Plans - خودرو بانک
Tools to assess Immunic Inc.’s risk profile2025 Stock Rankings & Real-Time Chart Breakout Alerts - newser.com
Immunic Inc.’s volatility index tracking explained2025 Pullback Review & Free Growth Oriented Trading Recommendations - newser.com
Using data tools to time your Immunic Inc. exitWeekly Trend Report & AI Powered Market Entry Strategies - newser.com
Is it time to cut losses on Immunic Inc.Trade Volume Summary & High Accuracy Investment Signals - newser.com
What machine learning models say about Immunic Inc.2025 Growth vs Value & Smart Allocation Stock Reports - Newser
Key metrics from Immunic Inc.’s quarterly dataJuly 2025 Levels & Technical Buy Zone Confirmations - Newser
What moving averages say about Immunic Inc.Earnings Recap Summary & Real-Time Volume Analysis Alerts - Newser
What’s next for Immunic Inc. stock pricePrice Action & Stepwise Entry/Exit Trade Alerts - Newser
Can trapped investors hope for a rebound in Immunic Inc.July 2025 Big Picture & Safe Entry Point Identification - Newser
Using flow based indicators on Immunic Inc.July 2025 Catalysts & Daily Risk Controlled Trade Plans - Newser
Visual trend scoring systems applied to Immunic Inc.Weekly Trade Summary & Real-Time Sentiment Analysis - Newser
Visual analytics tools that track Immunic Inc. performanceMarket Performance Recap & Stock Timing and Entry Methods - Newser
Combining machine learning predictions for Immunic Inc.Analyst Downgrade & Stepwise Entry and Exit Trade Signals - Newser
Market reaction to Immunic Inc.’s recent newsTake Profit & Daily Growth Stock Investment Tips - Newser
Is Immunic Inc. a candidate for recovery playPortfolio Risk Summary & Stock Market Timing Techniques - Newser
Analyzing drawdowns of Immunic Inc. with statistical toolsPortfolio Gains Report & Community Driven Trade Alerts - Newser
Identifying reversal signals in Immunic Inc.2025 Technical Overview & Safe Capital Growth Stock Tips - Newser
Intraday pattern recognizer results for Immunic Inc.July 2025 Weekly Recap & Trade Opportunity Analysis - Newser
Multi asset correlation models including Immunic Inc.2025 Fundamental Recap & Reliable Price Breakout Alerts - Newser
Will Immunic Inc. continue its uptrendQuarterly Profit Review & Capital Efficiency Focused Strategies - Newser
heatmap analysis for immunic inc. and competitorsJuly 2025 News Drivers & Weekly High Return Stock Forecasts - Newser
Immunic receives patent for multiple sclerosis treatment dose strengths By Investing.com - Investing.com Australia
Analyzing recovery setups for Immunic Inc. investorsPortfolio Risk Report & Reliable Entry Point Alerts - Newser
Immunic receives notice of allowance for vidofludimus calcium patent - MSN
Backtesting results for Immunic Inc. trading strategiesJuly 2025 WrapUp & Free Technical Pattern Based Buy Signals - Newser
Using Ichimoku Cloud for Immunic Inc. technicalsMarket Weekly Review & Verified Chart Pattern Trade Signals - Newser
Immunic secures US patent protection for vidofludimus calcium in dose strengths in progressive MS - Proactive financial news
Immunic receives patent for multiple sclerosis treatment dose strengths - Investing.com
Immunic receives notice of allowance for US Patent protecting vidofludimus calcium's dose strengths - MarketScreener
EQS-News: Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis - Ariva
Immunic Secures Patent for MS Drug Vidofludimus Through 2041 | IMUX Stock News - Stock Titan
Immunic Inc (IMUX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Immunic Inc 주식 (IMUX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Tardio Jason | President and COO |
Jun 05 '25 |
Buy |
0.79 |
12,512 |
9,884 |
12,512 |
| Vitt Daniel | CEO and Director |
Jun 04 '25 |
Buy |
0.77 |
15,000 |
11,550 |
29,000 |
| Neermann Joerg | Director |
Jun 04 '25 |
Buy |
0.77 |
70,000 |
53,900 |
170,000 |
| Neermann Joerg | Director |
Jun 05 '25 |
Buy |
0.76 |
30,000 |
22,800 |
200,000 |
| Whaley Glenn | Chief Financial Officer |
Jun 03 '25 |
Buy |
0.71 |
45,000 |
32,076 |
95,510 |
| Rudick Richard Alan | Director |
Jun 03 '25 |
Buy |
0.70 |
143,075 |
100,024 |
230,375 |
| Rudick Richard Alan | Director |
Nov 12 '24 |
Buy |
1.15 |
87,300 |
100,369 |
87,300 |
0.25%
0.14%
자본화:
|
볼륨(24시간):